Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Clinical trial NCT06451172 · RECRUITING

Trial details

NCT number: NCT06451172
Sponsor: Eye & ENT Hospital of Fudan University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Bacterial Keratitis Antibiotic-resistant Bacteria Infections, Bacterial Corneal Diseases Eye Diseases Vision Disorders Sensation Disorders Blindness Antisense Peptide Nucleic Acid Antibacterial Therapy

Start date: 2023-10-11
Primary completion: 2024-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.